More on 500087

- Summary
- Chart
- Profile
- Historical

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Friends, Peers and Foes (?): CPLFY, EQCIPLA, CIPLA.NS, CIPLA.BO, CIPLA.EQ (more...)

Jul 28, 2026 08:00 AM Cipla wins FDA approval for generic Advair Diskus in all strengths
Jul 28, 2026 08:00 AM Cipla Receives U.S. FDA Approval for Generic Advair Diskus®
Apr 23, 2026 09:04 AM Cipla receives FDA approval for first generic Ventolin HFA
Apr 23, 2026 09:04 AM Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA
Apr 2, 2026 11:11 PM Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis
Feb 27, 2026 11:28 AM Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy
Nov 17, 2025 08:30 AM Cipla USA Strengthens Lung Leadership with Community Wellness Initiatives
View All Articles

Entities mentioned with 500087

View All Entities